Structural Optimization of Decoy Oligonucleotide-Based PROTAC That Degrades the Estrogen Receptor-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Structural Optimization of Decoy Oligonucleotide-Based PROTAC That Degrades the Estrogen Receptor

Published:2023-09-22 Issue:10 Volume:34 Page:1780-1788
ISSN:1043-1802
Container-title:Bioconjugate Chemistry
language:en
Short-container-title:Bioconjugate Chem.

Author:

Naganuma Miyako¹²,Ohoka Nobumichi³^ORCID,Tsuji Genichiro¹^ORCID,Inoue Takao³,Naito Mikihiko⁴^ORCID,Demizu Yosuke¹²^ORCID

Affiliation:

1. Division of Organic Chemistry, National Institute of Health Sciences, Kanagawa 210-9501, Japan

2. Graduate School of Medical Life Science, Yokohama City University, Kanagawa 236-0027, Japan

3. Division of Molecular Target and Gene Therapy Products, National Institute of Health Sciences, Kanagawa 210-9501, Japan

4. Laboratory of Targeted Protein Degradation, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo 110-0033, Japan

Funder

Japan Agency for Medical Research and Development

Japan Society for the Promotion of Science

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Pharmaceutical Science,Pharmacology,Biomedical Engineering,Bioengineering,Biotechnology

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.bioconjchem.3c00332

Reference26 articles.

1. PROTAC targeted protein degraders: the past is prologue

2. Recent Developments in PROTAC‐Mediated Protein Degradation: From Bench to Clinic

3. Proteolysis targeting chimera (PROTAC) in drug discovery paradigm: Recent progress and future challenges

4. PROTACs: great opportunities for academia and industry (an update from 2020 to 2021)

5. Aptamer-Based Targeted Protein Degradation

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characteristic roadmap of linker governs the rational design of PROTACs;Acta Pharmaceutica Sinica B;2024-04

2. Synergizing Proteolysis-Targeting Chimeras and Nanoscale Exosome-Based Delivery Mechanisms for HIV and Antiviral Therapeutics;ACS Applied Nano Materials;2024-02-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3